title: Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa.
authors.forename: R
authors.initials: R
authors.lastname: Cheingsong-Popov
authors.forename: C
authors.initials: C
authors.lastname: Williamson
authors.forename: S
authors.initials: S
authors.lastname: Lister
authors.forename: L
authors.initials: L
authors.lastname: Morris
authors.forename: J
authors.initials: J
authors.lastname: van Harmelen
authors.forename: H
authors.initials: H
authors.lastname: Bredell
authors.forename: R
authors.initials: R
authors.lastname: Wood
authors.forename: P
authors.initials: P
authors.lastname: Sonnenberg
authors.forename: E
authors.initials: E
authors.lastname: van der Ryst
authors.forename: D
authors.initials: D
authors.lastname: Martin
authors.forename: J
authors.initials: J
authors.lastname: Weber
mesh_terms: D004196:Disease Outbreaks; D005260:Female; D015483:HIV Antibodies / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000145:classification / Q000276:immunology*; D015658:HIV Infections / Q000453:epidemiology / Q000821:virology*; D015497:HIV-1 / Q000145:classification* / Q000235:genetics; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000145:classification / Q000276:immunology*; D012680:Sensitivity and Specificity; D012703:Serotyping; D013019:South Africa / Q000453:epidemiology
chemical_list: D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments